This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Eosinophil Markers and Development of Disease in Allergic Rhinitis

This study has been completed.
Aarhus University Hospital
Information provided by:
University of Aarhus Identifier:
First received: August 30, 2010
Last updated: August 31, 2010
Last verified: August 2010
Inflammatory proteins from eosinophil granulocytes in blood from patients with seasonal allergic hayfever have been shown to predict development of asthma at a six-year follow-up. This study is a 15-year follow-up of the same patients to verify earlier results and study disease development.

Seasonal Allergic Rhinitis

Study Type: Observational
Official Title: Eosinophil Markers and Development of Disease in Allergic Rhinitis. A 15-year Follow-up of Patients With Grass Pollen Induced Hayfever.

Resource links provided by NLM:

Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Asthma morbidity [ Time Frame: Single measurement - May 2010 ]
    Patients are asked whether they have experienced asthmatic symptoms or have been disgnosed with asthma within the latest 15 years

Secondary Outcome Measures:
  • Rhinitis morbidity [ Time Frame: Single measurement - May 2010 ]
    Patients are asked for current hayfever symptoms

Enrollment: 29
Study Start Date: May 2010
Study Completion Date: May 2010
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Detailed Description:

The study consists of a single visit at which patients fill in a questionnaire on actual hayfever and asthma symptoms as well as current treatment. Blood samples and nasal lavages are drawn and analysed for eosinophils as well as eosinophil cationic protein and tryptase. Spirometry is performed.

If patients use drugs which can interfere with results, ie. corticosteroids or beta-agonists, biochemistry and/or spirometry are omitted.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Follow-up on participants in Allergic Rhinitis study 1995.

Inclusion Criteria:

  • Participant in earlier study (1995)

Exclusion Criteria:

  • Treatment with any kind of corticosteroid within two months will exclude from study of inflammatory parameters
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01192386

Sponsors and Collaborators
University of Aarhus
Aarhus University Hospital
Principal Investigator: Lars Peter Nielsen, MD Department of Respiratory Research, Aarhus University Hospital, DK-8000 Aarhus C, Denmark
  More Information

Responsible Party: Ass. professor Lars Peter Nielsen, Department of Respiratory Research, Aarhus University Hospital Identifier: NCT01192386     History of Changes
Other Study ID Numbers: RHINO2010
Study First Received: August 30, 2010
Last Updated: August 31, 2010

Additional relevant MeSH terms:
Rhinitis, Allergic
Rhinitis, Allergic, Seasonal
Nose Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases processed this record on June 23, 2017